A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Clinical trial NCT06980480 · RECRUITING

Trial details

NCT number: NCT06980480
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma Secondary Immunodeficiency

Start date: 2026-01-14
Primary completion: 2028-09-11
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.